Drug Discovery Services
Domainex is the fastest growing CRO in Europe. By applying our novel proprietary technologies such as CDH and taking a focussed, integrated approach to medicinal chemistry, biochemistry and computational chemistry we can reduce your project timeline by up to 30%.
New technologies
Domainex has launched its new PoLiPa technology, which can purify any GPCR without the need for thermostabilising mutations or detergents by encapsulating it in a polymer along with a small disc of the native cell membrane lipids. PoLiPa-GPCRs are pharmacologically intact and very stable.
Technology
FragmentBuilder: Fragment screening using MicroScale Thermophoresis
Combinatorial Domain Hunting: Protein expression and purification services.
BioassayBuilder: Bioassay services, assay development, HTS and compound testing services.
LeadBuilder: Virtual hit screening platform.